Personalis, Inc.
Personalis is a leader in advanced cancer genomics for enabling the next generation of precision cancer therapies and diagnostics. The Personalis NeXT Platform® is designed to adapt to the complex & evolving understanding of cancer, providing its biopharmaceutical customers & clinicians with information on all of the approximately 20,000 human genes, together with the immune system, from a single tissue sample. To enable cancer sequencing, our Clinical Lab was built with a focus on clinical accuracy, quality, big data, scale, & efficiency, & is GxP aligned, CLIA’88-certified & CAP-accredited.
Additional Info
Will your company display a new product or promote a new indication/enhanced feature(s) for an existing product in your booth?
Yes